bipolar disorder in practice Flashcards

1
Q

what is bipolar affective disorder?

A

A chronic relapsing and remitting disorder
• Abnormally elevated mood or irritability alternates with depressed mood
• In most cases depressive episodes are more frequent than manic ones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is BPAD associated with?

A

BPAD is associated with poor physical health and drug treatments can add to this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what does NICE recommend for a patient with BPAD each year?

A

NICE recommends a physical health check at least annually for people with bipolar disorder, to include
– weight or BMI
– diet
– nutritional status and level of physical activity;
– cardiovascular status, including pulse and blood pressure;
– metabolic status, including fasting blood glucose, HbA1c, prolactin, blood lipid profile, liver function.
– If prescribed lithium also renal function/TFTs and calcium levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is done if there is suspected bipolar disorder?

A

People with suspected bipolar disorder are all
referred to specialist mental health services
• Advice before any medication changes while
awaiting assessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how is treatment determined?

A
determined by the phase of illness and subtype of disorder
• Individual variation in response to medication will often determine the choice of drug, as will;
– age
– side effects
– interactions and associated cautions
– child-bearing potential
– previous history
– medical comorbidities
– individual preferences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how would you manage acute hypomania?

A
• Assessment of patient
– Triggers, Medication adherence 
• Consider withdrawing any existing
– Antidepressant therapy
– Stimulants
• If not currently prescribed an antipsychotic or mood stabiliser
initiate 
• If already taking lithium, check plasma levels and optimise. 
Consider adding antipsychotic. 
 Short term use of benzodiazepine can be considered for severe agitation ( 
concern over dependence and withdrawal)
• Psychotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what antispychotic/ mood stabliser would you give for acute hypomania?

A

– Haloperidol, olanzapine, quetiapine, risperidone
– If poorly tolerated or ineffective at max licensed dose, select alternative
– If not sufficient consider adding lithium or if not suitable valproate (see
pregnancy prevention programme later in lecture)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when should long term treatment for hypomania be discussed?

A

Long-term treatment should be discussed within 4 weeks of resolution of symptoms following acute treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how would you treat long term hypomania?

A

If appropriate, treatment for acute episodes can continue for a further 3–6 months, and then should be reviewed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the agents that are NOT recommended for use in mania?

A

 Antidepressants (induce mania)
 Lamotrigine (bipolar depression)
 Gabapentin, topiramate
 Carbamazepine + antipsychotics metabolized primarily by CYP3A4 (interaction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what treeatment is recommended for bipolar depression?

A

Antidepressant monotherapy NOT recommended
– NICE recommends fluoxetine + olanzapine
– Atypical antipyschotic e.g. olanzapine,quetiapine
– Consider Lamotrigine if no response to above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what should be avoided in the treatment of bipolar depression?

A

– Tricyclic antidepressants and venlafaxine avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what should be discussed within 4 weeks of resolution of symptoms of bipolar depression?

A

iscuss with patient whether to continue psychological or pharmacological treatment for bipolar depression or start long-term treatment
• If continued offer for further 3-6 months then review
– Discontinuation recommended to reduce risk of switching to mania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what treatment should be used for long-term management of bipolar depression?

A

• Prophylaxis indicated
– after manic episode with significant risk
– 2 or more acute episodes bipolar I disorder
– Significant functional impairment or suicide risk
• First line tx lithium, valproate* or olanzapine
• Second line tx
– Lamotrigine (as adjunct) or carbamazepine
• Tx continued at least 2 years after episode
• Reduce treatments gradually on withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what must stay the same when prescribing lithium?

A

Lithium MUST be prescribed by NAME and BRAND
• Should not be initiated in primary care without specialist advice
Secondary care or shared care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how long of a trial is needed for lithium?

A

at least a 6 month trial to est efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what therapeutic effects does lithium have?

A

– Acute mania
– Prophylactic agent for mania and depression
– Antidepressant properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is first line to treat bipolar depression to prevent relapse?

A

lithium

19
Q

how long should lithium monitoring occur?

A

t least every 6 months during treatment

more frequently in early stages of treatment

20
Q

what do you monitor with lithium?

A
• Serum electrolytes
• eGFR
• Body-weight/BMI/waist 
circumference/lipids
• Thyroid function 
• Calcium levels
• (Also monitor FBC on initiation plus ECG 
if cardiac risk factors)
21
Q

how often do you monitor lithium?

A

Therapeutic drug monitoring (lithium levels) at least every 3-6 months
• initially weekly
• Additional tests if concerns e.g. signs of toxicity
• Additional test 5-7 days after every dose change or starting/stopping
interacting drugs

22
Q

when should you take lithium levels?

A

Take levels 12 hours post dose (10-14 hrs probably OK in practice)

23
Q

what are the lithium levels for initial treatment?

A

– Lithium levels for initial treatment
• 0.6-0.8 mmol/L
• 0.8–1.0 mmol/L

24
Q

who is the higher range of lithium levels suitable for?

A

The higher range above suitable for people who have relapsed
previously while taking lithium or who still have sub-threshold
symptoms with functional impairment while receiving lithium

25
Q

what levels indicate lithium toxicity?

A

toxicicty more common in lithium levels>1.5mmol/L

26
Q

what are the side effects of lithium?

A
• Fine tremor
• Sedation
• Impaired co-ordination
• GI disturbances
• Polyuria, polydipsia
• QT prolongation
• Longer term effects
– Weight changes
– Thyroid disorders
– Hyperparathyroidism
– Renal impairment
27
Q

what are the signs of lithium toxicity?

A
• Lack of appetite , diarrhoea and 
vomiting
• Blurred vision
• Marked tremor 
• Unsteadiness , slurred speech 
• Drowsiness and confusion
• At levels > 2mmol/L: 
– muscle twitches 
– more severe drowsiness and 
confusion
– Convulsions 
– unconsciousness
28
Q

what are the main interactions with lithium?

A
• Generally anything that impacts on renal 
function or sodium levels
–Diuretics
–NSAIDs
–ACE inhibitors
–Antidepressants (serotonin syndrome)
• Carbamazepine
• Haloperidol
29
Q

are lithium tablets are liquid interchangable?

A
  • Liquid and tablets are not interchangeable
  • Dose conversion
  • Lithium carbonate = tablets
  • Lithium citrate = liquid
  • 200mg tablets = 509mg liquid
  • 204mg tablets = 520mg liquid
30
Q

what should the lithium starter pack entail?

A

info

booklet, alert card, record book for tracking serum-lithium concentration.

31
Q

how should a patient be counselled on lithium?

A

Take lithium every day. Try not to miss any doses.
• To carry a lithium card at all times
• Advise patient that each time they collect prescription check the brand is the
same as usual
• Tell pharmacist before buying any OTC products or supermarket medications
• Maintain adequate fluid intake to avoid dehydration
• Avoid dietary changes that reduce or increase sodium intake
• Will need to have regular blood tests- dose may be adjusted
depending on the results of the blood tests.
• Check before taking other medications..–OTC and prescribed
e.g. nonsteroidal anti-inflammatory drugs
• Women of childbearing age should be advised to use reliable
contraception.
• Managing missed doses
• Common side effects, such as dry mouth or metallic taste in
mouth, feeling thirsty, weight gain, fluid retention. Try to drink
low calorie drinks to avoid weight gain.
recogise signs of toxicity
seek medical advise if become dehydrated

32
Q

what are some important practial points for lithium for the pharmacist?

A

Usually given at night (trough serum lithium level can
be taken in the morning 12 hrs post dose)
• If twice daily dosing- morning dose should be taken
after taking lithium level to avoid high readings
• Patients admitted to hospital on lithium –check bloods
• Ensure additional blood tests if signs of renal
impairment, toxicity etc
• Check lithium book and ensure kept up to date
• Be vigilant for drug interactions and signs of toxicity
• Patient education/supporting adherence

33
Q

what is valporate used for?

A

–Acute mania

–Prophylactic agent

34
Q

what is valporate available as?

A

sodium valproate,

valproic acid, semi-sodium valproate.

35
Q

what are semisodium and sodium valporate metabolised to?

A

valproic acid, which is responsible for

the pharmacological activity of all three preparations

36
Q

what is an important point to tell women of child bearing age when on valporate?

A

– To be provided with a patient card every time valproate is dispensed
– For valproate to be dispensed with a copy of the PIL , and if repackaged, with a warning on the container supplied as well
– To be reminded of the risks in pregnancy and the need for highly effective contraception, and a reminder of the need for annual specialist review
– To be asked if they have received the patient guide

37
Q

what are the side effects of valporate?

A
– Weight gain
– GI irritation
– Blood disorders
– Impaired Liver function
– Pancreatitis
– Fatigue, nausea, sedation, hair loss
– Risk of suicidal thoughts
– Tetatogenic
38
Q

what interactions occur with valporate?

A

Highly protein bound (up to 94%), therefore may be displaced
from albumin precipitating toxicity
• Other less strongly protein-bound drugs (e.g. warfarin) can be
displaced by valproate; this may lead to higher free levels and
increased therapeutic effect or toxicity of the concomitant
drug.
• Valproate is metabolized by the liver, so drugs that inhibit
cytochrome P450 enzymes can increase valproate levels.

39
Q

what is the preferred treatment option for acute mania?

A

Olanzapine, quetiapine,

aripiprazole

40
Q

what is the longer term effects of atypical antipsychotics?

A
– Weight gain
– Dyslipidaemia
– Hyperprolactinaemia
• may lead to galactorrhea, amenorrhoea, gynaecomastia, hypogonadism, sexual dysfunction, and an increased risk of osteoporosis. 
– Hypertension
• A small, steady increase in blood pressure over time (may be associated with weight gain), or
• An unpredictable, sharp increase in blood pressure on starting a new drug.
– Reduced seizure threshold
– Impaired glucose tolerance 
– QT interval prolongation
– Stroke risk 
– Venous thromboembolism (VTE)
41
Q

what is lamotrigine licensed in the UK for?

A

for prevention of depressive disorders in bipolar I disorder but not for treatment of acute manic or depressive episodes

42
Q

what are the side effects of lamotrigine?

A

– Skin rashes
• Must be promptly evaluated and lamotrigine withdrawn immediately unless the rash is clearly not drug related.
– Headache, dizziness, nausea, drowsiness, insomnia
– Blood disorders (rarely)
– Small risk of suicidal thoughts and behaviours

43
Q

what interactions are there with lamotrigine?

A

– Plasma concentration of lamotrigine is reduced by phenytoin, primidone, carbamazepine, oestrogens, and progestogens.
• The dose of lamotrigine may need to be increased.
– Plasma concentration of lamotrigine is increased by valproate.

44
Q

what are some non pharmacological interventions for bipolar disorder?

A
• Patient education
– Coping strategies
• Regular routine & sleep hygiene
• Detecting early warning symptoms
– Concordance with medication & blood monitoring
• Cognitive Behavioural Therapy
– Individual or group
• Psychosocial support
• ECT Therapy
– Limited use
– Severe bipolar unresponsive to multiple medications